Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C

被引:17
作者
Kondo, Y
Kobayashi, K
Kobayashi, T
Shiina, M
Ueno, Y
Satoh, T
Shimosegawa, T
机构
[1] Tohoku Univ, Grad Sch Med, Dept Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Hlth Sci, Sendai, Miyagi 9808575, Japan
[3] Furukawa City Hosp, Dept Internal Med, Fukukawa 9196183, Japan
[4] Sendai Natl Hosp, Dept Gastroenterol, Sendai, Miyagi 9830045, Japan
[5] Sendai Shakaihoken Hosp, Ctr Renal Dis, Sendai, Miyagi 9810912, Japan
关键词
HLA class I allele; HLA-A2; CTL; cellular immune response; Japanese individuals;
D O I
10.1620/tjem.201.109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An essential process for resolution of viral infections is the efficient recognition and elimination of intracellular virus. Recognition of viral antigens in the form of short peptides associated with HLA class I molecule is a major task of CD8(+) cytotoxic T lymphocytes. In this study, we have evaluated the frequency of the HLA class I alleles in patients with chronic hepatitis C. HLA-B51, -B52, -B55, -B56, -B61, B70, -Cw1, -Cw3, and -Cw4 are less frequent in patients with chronic hepatitis C than in Japanese individuals. The frequency of HLA-A2 is slightly lower in the patients but tends to be higher in patients with normal alanine aminotransferase (ALT) level than in those with elevated ALT level (p = 0.07). Other HLA alleles are not significantly different between two groups. Comparison of HLA homozygosity at HLA-A and -B or -C or at two or three loci did not show a significant association with levels of serum ALT or with the clinical outcome of interferon therapy in patients with hepatitis C. These results suggest a possibility that the alterations of host response, which depends on genetic background, influence disease activities of HCV infection.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 22 条
[1]   A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors [J].
Boyington, JC ;
Sun, PD .
MOLECULAR IMMUNOLOGY, 2002, 38 (14) :1007-1021
[2]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[3]   An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction [J].
Chang, GYN .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (03) :267-268
[4]  
DIANZANI F, 1993, GUT, V34, P74
[5]   ENHANCED IMMUNOLOGICAL SURVEILLANCE IN MICE HETEROZYGOUS AT H-2 GENE COMPLEX [J].
DOHERTY, PC ;
ZINKERNAGEL, RM .
NATURE, 1975, 256 (5512) :50-52
[6]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299
[7]   GENE-FREQUENCIES AND HAPLOTYPIC ASSOCIATIONS WITHIN THE HLA REGION IN 916 UNRELATED JAPANESE INDIVIDUALS [J].
HASHIMOTO, M ;
KINOSHITA, T ;
YAMASAKI, M ;
TANAKA, H ;
IMANISHI, T ;
IHARA, H ;
ICHIKAWA, Y ;
FUKUNISHI, T .
TISSUE ANTIGENS, 1994, 44 (03) :166-173
[8]   Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection [J].
Hiroishi, K ;
Kita, H ;
Kojima, M ;
Okamoto, H ;
Moriyama, T ;
Kaneko, T ;
Ishikawa, T ;
Ohnishi, S ;
Aikawa, T ;
Tanaka, N ;
Yazaki, Y ;
Mitamura, K ;
Imawari, M .
HEPATOLOGY, 1997, 25 (03) :705-712
[9]  
HOOFNAGLE JH, 1993, J HEPATOL S3, V17, P130
[10]  
Kuzushita N, 1996, J MED VIROL, V48, P1